BenBedPhar Training School 2024
We invite applications from early career researchers (Postdocs and PhDs), who are members of the BenBedPhar EU Cost Action CA20121 ‘Bench to bedside transition for pharmacological regulation of NRF2 in non-communicable diseases’ to attend a Training School focused on the importance of ‘Physiological oxygen levels to investigate NRF2 regulated redox signaling in cell biology to improve clinical translation.
ECRs are encouraged to apply and to submit an Abstract (~250-300 words, see template below) together with a brief biosketch and photo. Selected applicants will be able to present their current research as oral presentations and also interact closely with experts in the field. The Training School
will be held at King’s College London in the UK from 5-8 March 2024 and please contact Prof GE Mann (giovanni.mann@kcl.ac.uk) for any further information or assistance.
King’s British Heart Foundation Centre of Research Excellence School of Cardiovascular Medicine & Sciences Faculty of Life Sciences & Medicine King’s College London, UK (WP 2 member)
Email: giovanni.mann@kcl.ac.uk
URL: https://www.kcl.ac.uk/people/giovanni-e-mann
King’s British Heart Foundation Centre of Research Excellence School of Cardiovascular and Metabolic Medicine & Sciences Faculty of Life Sciences & Medicine Director Ageing Research at King’s (ARK)
Email: richard.siow@kcl.ac.uk
URL: https://www.kcl.ac.uk/people/richard-siow
The Training School will provide informative research seminars and hands-on training for trainees in a state-of-the-art Physiological Oxygen Laboratory based in the King’s British Heart Foundation Centre of Research Excellence, King’s College London, U.K.
https://www.kcl.ac.uk/research/physiological-oxygen-laboratory
This Training School is supported by an EU COST Action CA20121 ‘Bench to bedside transition for pharmacological regulation of NRF2 in non-communicable diseases’ (https://benbedphar.org). The Training School aims to highlight the importance of the KEAP1/NRF2 defense pathway in cellular redox signaling, focusing particularly on studies of NRF2 signaling in cells cultured under physiological oxygen levels. Trainees will be able to attend an informative seminar programme in which established researchers will provide up-to-date overviews of the importance of targeting NRF2 in health and disease. We have also invited clinicians in the field of neurodegeneration to provide trainees with insights into clinical treatment for Alzheimer’s and Parkinson’s disease.
Researchers from Baker, BMG Labtech, BioGenium Microsystems and Lucid Scientific will present talks on the use of oxygen controlled Baker workstations, oxygen controlled CLARIOstar plate reader, portable oxygen controlled Oxygenie and novel Recipher apparatus to measure oxygen consumption rate in living cells. In afternoon sessions, trainees would be guided on the use of the facilities by Training School Staff (see appended programme).
TheTraining School has capacity for 10-12 trainees of which BenBedPhar will defray registration, the cost of travel and provide an allowance (to cover accommodation, catering and short-distance travel) for trainees. Trainees will be selected from PhD students and Early Career Researchers (ECRs) participating in the BenBedPhar project, considering quality of their submitted abstract and gender and geographical balance. Attending Trainees will present their research during 15-min presentations.
Abstracts will be compiled in an Abstract Booklet together with the programme and speaker biography. Prof Mann is liaising with Elsevier to enquire whether abstracts from the Training School can be published in Free Radical Biology & Medicine.
TheTraining School has capacity for 10-12 trainees of which BenBedPhar will defray registration, the cost of travel and provide an allowance (to cover accommodation, catering and short-distance travel) for trainees. Trainees will be selected from PhD students and Early Career Researchers (ECRs) participating in the BenBedPhar project, considering quality of their submitted abstract and gender and geographical balance.Attending Trainees will present their research during 15-min presentations.
Please email your letter of application and abstract [250-300 words, Title, Author(s), Institution, Email] to Prof GE Mann (giovanni.mann@kcl.ac.uk) by 5 February. All abstracts will be compiled in an Abstract Booklet together with the programme and speaker biography. Prof Mann is liaising with Elsevier to enquire whether abstracts from the Training School can be published in Free Radical Biology & Medicine.
Deadline for abstract submission is February 5, 2024
Department of Imaging Chemistry and Biology School of Biomedical Engineering & Imaging Sciences Faculty of Life Sciences & Medicine King’s College London, UK
Email: philip.blower@kcl.ac.uk
URL: https://www.kcl.ac.uk/people/phil-blower
Jacqui Wood Cancer Centre Division of Cellular Medicine Ninewells Hospital and Medical School University of Dundee Scotland, UK
Email: j.d.hayes@dundee.ac.uk
URL: https://www.dundee.ac.uk/people/john-hayes
School of Medicine University College Dublin Dublin, Ireland
Email: cormac.taylor@ucd.ie
URL: https://people.ucd.ie/cormac.taylor
Assistant Professor Research Institute for Health Sciences & Technologies (SABITA) Istanbul Medipol University, Turkey (WP2 member)
Email: emrah.eroglu@medipol.edu.tr
URL: https://sabita.medipol.edu.tr/
CEO, Lucid Scientific
Email: winman@lucidsci.com
URL: https://atdc.org/portfolio-overview/atdc-signature/lucid-scientific/
Postdoctoral Research Associate, Physiological Oxygen Laboratory, King’s BHF Centre of Research Excellence, King’s College London
Email: fan.4.yang@kcl.ac.uk
MedTechONE Fellow, Imperial College London, U.K.
Email: d.simon19@imperial.ac.uk
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Grant Holder: Universidad Autónoma de Madrid
Start of Action: 19 October, 2021
End of Action: 18 October, 2025
Entry into force: DATE HERE
CSO approval date: 25 May 2021
Action email: info@benbedphar.org